Takagi, M.; Maeda, S.; Maeda, M.; Fujio, Y.; Hirobe, S.
Effects of Modifying Supportive Care Medications in Combination Therapy with Pertuzumab, Trastuzumab, and Taxane Anticancer Drugs. Pharmacy 2025, 13, 168.
https://doi.org/10.3390/pharmacy13060168
AMA Style
Takagi M, Maeda S, Maeda M, Fujio Y, Hirobe S.
Effects of Modifying Supportive Care Medications in Combination Therapy with Pertuzumab, Trastuzumab, and Taxane Anticancer Drugs. Pharmacy. 2025; 13(6):168.
https://doi.org/10.3390/pharmacy13060168
Chicago/Turabian Style
Takagi, Mina, Shinichiro Maeda, Makiko Maeda, Yasushi Fujio, and Sachiko Hirobe.
2025. "Effects of Modifying Supportive Care Medications in Combination Therapy with Pertuzumab, Trastuzumab, and Taxane Anticancer Drugs" Pharmacy 13, no. 6: 168.
https://doi.org/10.3390/pharmacy13060168
APA Style
Takagi, M., Maeda, S., Maeda, M., Fujio, Y., & Hirobe, S.
(2025). Effects of Modifying Supportive Care Medications in Combination Therapy with Pertuzumab, Trastuzumab, and Taxane Anticancer Drugs. Pharmacy, 13(6), 168.
https://doi.org/10.3390/pharmacy13060168